Cleared Traditional

K973363 - NORTH AMERICAN SCIENTIFIC(NASI)PD-103 RADIONUCLIDE BRACHYTHERAPY SOURCE-MODEL MED3633
(FDA 510(k) Clearance)

Jul 1998
Decision
297d
Days
Class 2
Risk

K973363 is an FDA 510(k) clearance for the NORTH AMERICAN SCIENTIFIC(NASI)PD-103 RADIONUCLIDE BRACHYTHERAPY SOURCE-MODEL MED3633. This device is classified as a Source, Isotope, Sealed, Gold, Titanium, Platinum (Class II - Special Controls, product code IWI).

Submitted by Ml Strategies, Inc. (Boston, US). The FDA issued a Cleared decision on July 2, 1998, 297 days after receiving the submission on September 8, 1997.

This device falls under the Radiology FDA review panel. Regulated under 21 CFR 892.5730.

Submission Details

510(k) Number K973363 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 08, 1997
Decision Date July 02, 1998
Days to Decision 297 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Statement

Device Classification

Product Code IWI — Source, Isotope, Sealed, Gold, Titanium, Platinum
Device Class Class II - Special Controls
CFR Regulation 21 CFR 892.5730